{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:48:28Z","timestamp":1791478108054,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10072-024-07678-3","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:37:02Z","timestamp":1720222622000},"page":"5511-5515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Successful treatment with efgartigimod as an add-on therapy in acute attack of anti-AQP4 antibody-positive NMOSD: a case report"],"prefix":"10.1007","volume":"45","author":[{"given":"Shi-Qi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Hua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0536-1131","authenticated-orcid":false,"given":"Jian-Quan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"7678_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMra1904655","volume":"387","author":"DM Wingerchuk","year":"2022","unstructured":"Wingerchuk DM, Lucchinetti CF (2022) Neuromyelitis Optica spectrum disorder. N Engl J Med 387:631\u2013639","journal-title":"N Engl J Med"},{"key":"7678_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","volume":"17","author":"A Bruscolini","year":"2018","unstructured":"Bruscolini A, Sacchetti M, La Cava M, Gharbiya M, Ralli M, Lambiase A, De Virgilio A, Greco A (2018) Diagnosis and management of neuromyelitis optica spectrum disorders - an update. Autoimmun Rev 17:195\u2013200","journal-title":"Autoimmun Rev"},{"key":"7678_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","volume":"271","author":"T K\u00fcmpfel","year":"2024","unstructured":"K\u00fcmpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, H\u00e4u\u00dfler V, Havla J, Hellwig K, H\u00fcmmert MW, Jarius S, Kleiter I (2024) Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: attack therapy and long-term management. J Neurol 271:141\u2013176","journal-title":"J Neurol"},{"key":"7678_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24554","volume":"79","author":"I Kleiter","year":"2016","unstructured":"Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M (2016) Neuromyelitis Optica: evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 79:206\u2013216","journal-title":"Ann Neurol"},{"key":"7678_CR5","doi-asserted-by":"publisher","first-page":"720907","DOI":"10.3389\/fimmu.2021.720907","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Cui C, Lu Y, Chang Y, Wang Y, Li R, Shan Y, Sun X, Long Y, Wang H, Wang Z (2021) Therapeutic response and possible biomarkers in acute attacks of neuromyelitis optica spectrum disorders: a prospective observational study. Front Immunol 12:720907","journal-title":"Front Immunol"},{"key":"7678_CR6","first-page":"577387","volume":"348","author":"X Ma","year":"2020","unstructured":"Ma X, Kermode AG, Hu X, Qiu W (2020) NMOSD acute attack: understanding, treatment and innovative treatment prospect. J Neurol 348:577387","journal-title":"J Neurol"},{"key":"7678_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","volume":"23","author":"M Pyzik","year":"2023","unstructured":"Pyzik M, Kozicky LK, Gandhi AK, Blumberg RS (2023) The therapeutic age of the neonatal fc receptor. Nat Rev Immunol 23:415\u2013432","journal-title":"Nat Rev Immunol"},{"key":"7678_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","volume":"20","author":"JF Howard Jr","year":"2021","unstructured":"Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A (2021) Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol 20:526\u2013536","journal-title":"Lancet Neurol"},{"key":"7678_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/mus.28003","volume":"69","author":"M Singer","year":"2024","unstructured":"Singer M, Khella S, Bird S, McIntosh P, Paudyal B, Wadhwani A, Quinn C, Karam C (2024) Single institution experience with efgartigimod in patients with myasthenia gravis: patient selection, dosing schedules, treatment response, and adverse events. Muscle Nerve 69:87\u201392","journal-title":"Muscle Nerve"},{"key":"7678_CR10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jca.22002","volume":"37","author":"MH Tran","year":"2022","unstructured":"Tran MH (2022) Plasma exchange in a bottle: an overview of efgartigimod for apheresis practitioners. J Clin Apher 37:512\u2013515","journal-title":"J Clin Apher"},{"key":"7678_CR11","doi-asserted-by":"publisher","first-page":"e200124","DOI":"10.1212\/NXI.0000000000200124","volume":"10","author":"F Paul","year":"2023","unstructured":"Paul F, Marignier R, Palace J, Arrambide G, Asgari N, Bennett JL, Cree BA, De S\u00e8ze J, Fujihara K, Kim HJ, Hornby R (2023) International Delphi consensus on the management of AQP4-IgG\u2009+\u2009NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab. Neurol Neuroimmunol Neuroinflamm 10:e200124","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7678_CR12","doi-asserted-by":"publisher","first-page":"e30421","DOI":"10.1016\/j.heliyon.2024.e30421","volume":"10","author":"Z Li","year":"2024","unstructured":"Li Z, Xu Q, Huang J, Zhu Q, Yang X, Zhang M, Zhang S, Huang S, Yu G, Zheng P, Qin X (2024) Efgartigimod as rescue treatment in acute phase of neuromyelitis optica spectrum disorder: a case report. Heliyon 10:e30421","journal-title":"Heliyon"},{"key":"7678_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40263-023-01003-w","volume":"37","author":"YA Heo","year":"2023","unstructured":"Heo YA (2023) Correction to: efgartigimod alfa in generalised myasthenia gravis: a profile of its use. CNS Drugs 37:475","journal-title":"CNS Drugs"},{"key":"7678_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/ene.15561","volume":"30","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhong X, Wang H, Peng Y, Shi F, Jia D, Yang H, Zeng Q, Quan C, ZhangBao J, Lee M (2023) Batoclimab as an add-on therapy in neuromyelitis optica spectrum disorder patients with acute attacks. Eur J Neurol 30:195\u2013203","journal-title":"Eur J Neurol"},{"key":"7678_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1352458515581438","volume":"22","author":"H Abboud","year":"2016","unstructured":"Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M (2016) Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange. Mult Scler 22:185\u2013192","journal-title":"Mult Scler"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07678-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07678-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07678-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:07:08Z","timestamp":1728691628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07678-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7678"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07678-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they complied with ethical standards and the patient gave written informed consent for the publication of this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}